Jinchang Y. Huang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Correction: Case Report: Quantitative and qualitative evaluation for electroacupuncture combined with moxibustion in the treatment of recalcitrant low anterior resection syndrome.
Journal: Frontiers in medicine
Published: May 25, 2026
Case Report: Quantitative and qualitative evaluation for electroacupuncture combined with moxibustion in the treatment of recalcitrant low anterior resection syndrome.
Journal: Frontiers in medicine
Published: February 23, 2026
Reversing ABCB1-Mediated Multidrug Resistance in Colorectal Cancer: electroacupuncture shows therapeutic potential in vivo.
Journal: Journal of pharmacopuncture
Published: August 06, 2025
Mendelian randomization does not support the effects of G CSF on decompensated liver disease.
Journal: Clinical and molecular hepatology
Published: February 27, 2025
The role of mitochondria-related genes in hepatocellular carcinoma prognosis: construction of prognostic models based on machine learning.
Journal: Discover oncology
Published: December 21, 2024
Summary of Professor HUANG Jinchang's experience of electroacupuncture at Baliao acupoints for low anterior resection syndrome of rectal cancer
Journal: Zhongguo zhen jiu = Chinese acupuncture & moxibustion
Published: November 12, 2024
Efficacy of traditional Chinese medicine in the conservative management of complete small intestinal obstruction post-gastric cancer surgery: A case report.
Journal: Explore (New York, N.Y.)
Published: November 01, 2024
Xihuang pill suppresses triple-negative breast cancer via regulating AXL/TGF-β1/RhoA/ROCK and ERK pathway.
Journal: Journal of ethnopharmacology
Published: August 24, 2024
Electroacupuncture normalized tumor vasculature by downregulating glyoxalase-1 to polarize tumor-associated macrophage to M1 phenotype in triple-negative breast cancer.
Journal: International immunopharmacology
Published: July 04, 2024
Moxibustion combined with guasha therapy for recurrent neutropenia following multiple cycles of chemotherapy of ovarian cancer: A case report.
Journal: Explore (New York, N.Y.)
Published: June 17, 2024
Revealing the active ingredients and mechanisms of Xiatianwu against hepatocellular carcinoma: a study based on network pharmacology and bioinformatics.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 26, 2024
Last Updated: 09/26/2026